Gam Holding Ag Nektar Therapeutics Transaction History

Gam Holding Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$16.52 - $20.4 $849,177 - $1.05 Million	-51,403 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$16.56 - $25.46 $851,233 - $1.31 Million	51,403 New	51,403 $1.03 Million
Q4 2020 Feb 10, 2021	SELL	$15.77 - $19.03 $1.14 Million - $1.38 Million	-72,500 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$16.86 - $23.44 $296,736 - $412,544	17,600 Added 32.06%	72,500 $1.68 Million
Q1 2020 May 12, 2020	BUY	$14.47 - $27.96 $183,769 - $355,092	12,700 Added 30.09%	54,900 $980,000
Q1 2019 May 10, 2019	SELL	$31.58 - $46.35 $63 - $92	-2 Reduced -0.0%	42,200 $1.42 Million
Q4 2018 Feb 08, 2019	SELL	$30.43 - $56.65 $155,193 - $288,915	-5,100 Reduced 10.78%	42,202 $1.39 Million
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $492,568 - $726,130	10,602 Added 28.89%	47,302 $2.88 Million
Q2 2018 Aug 09, 2018	BUY	$46.25 - $104.45 $1.7 Million - $3.83 Million	36,700 New	36,700 $1.79 Million

146

140M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $157M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.